CLINICAL_TRIALS ClinicalTrials.gov record with results posted

An Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol® (Doxercalciferol Capsules) in Pediatric Patients With Chronic Kidney Disease Stages 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02859896
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-07-03T00:04:16.426564+00:00
Published At: 2026-07-02T00:00:00+00:00
Record Updated At: 2026-07-02
Results Posted At: 2026-07-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Secondary Hyperparathyroidism-Chronic Kidney Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-07-02"
protocolSection.identificationModule.nctId: "NCT02859896"
protocolSection.identificationModule.officialTitle: "An Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol\u00ae (Doxercalciferol Capsules) in Pediatric Patients With Chronic Kidney Disease Stages 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-07-02"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.